Immunogenicity is not increased with subcutaneous administration of abatacept with and without methotrexate in patients with rheumatoid arthritis: Results from a phase III study

0846

  • Nash, P
  • Nayiager, S
  • Genovese, M C
  • Kivitz, A J
  • Oelke, K
  • Ludivico, C
  • Palmer, W
  • Rodriguez, C
  • Delaet, I
  • Overfield, S
  • Elegbe, A
  • Corbo, M

  • 1University of Queensland, Brisbane, Australia

    2St Augustine's Hospital, Durban, South Africa

    3Stanford University, Palo Alto, CA, United States

    4Altoona Center for Clinical Research, Duncansville, PA, United States

    5Rheumatic Disease Center, Milwaukee, WI, United States

    6East Penn Rheumatology Associates, Bethlehem, PA, United States

    7Westroads Medical Group, Omaha, NE, United States

    8Bristol-Myers Squibb, Princeton, NJ, United States

International Journal of Rheumatic Diseases 13:p 103, July 2010.
Copyright © 2010 John Wiley & Sons, Inc.